Life Science REIT PLC (LABS) - Net Assets
Based on the latest financial reports, Life Science REIT PLC (LABS) has net assets worth GBX233.06 Million GBX (≈ $28.36K USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX374.95 Million ≈ $45.62K USD) and total liabilities (GBX141.89 Million ≈ $17.26K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read Life Science REIT PLC (LABS) total liabilities for a breakdown of total debt and financial obligations.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | GBX233.06 Million |
| % of Total Assets | 62.16% |
| Annual Growth Rate | -9.16% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 1.56 |
Life Science REIT PLC - Net Assets Trend (2021–2024)
This chart illustrates how Life Science REIT PLC's net assets have evolved over time, based on quarterly financial data. Also explore Life Science REIT PLC asset portfolio for the complete picture of this company's asset base.
Annual Net Assets for Life Science REIT PLC (2021–2024)
The table below shows the annual net assets of Life Science REIT PLC from 2021 to 2024. For live valuation and market cap data, see LABS market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | GBX262.77 Million ≈ $31.97K |
-7.39% |
| 2023-12-31 | GBX283.75 Million ≈ $34.52K |
-11.18% |
| 2022-12-31 | GBX319.45 Million ≈ $38.87K |
-8.88% |
| 2021-12-31 | GBX350.58 Million ≈ $42.66K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Life Science REIT PLC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 817.7% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | GBX3.50 Million | 1.33% |
| Other Comprehensive Income | GBX314.82 Million | 119.81% |
| Total Equity | GBX262.77 Million | 100.00% |
Life Science REIT PLC Competitors by Market Cap
The table below lists competitors of Life Science REIT PLC ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Rainbow Polikarbonat Sanayi Ticaret AS
IS:RNPOL
|
$1.84 Million |
|
Bridge Saas Ltd
AU:BGE
|
$1.84 Million |
|
ProAm Explorations Corp
V:PMX
|
$1.84 Million |
|
Fintech Chain Ltd
AU:FTC
|
$1.84 Million |
|
Middlefield Canadian Income PCC - Middlefield Canadian Income - GBP PC
LSE:MCT
|
$1.83 Million |
|
Monarca Minerals Inc
V:MMN
|
$1.83 Million |
|
Alexium International Group Limited
F:E7T
|
$1.83 Million |
|
Regional REIT Ltd
LSE:RGL
|
$1.83 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Life Science REIT PLC's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 283,745,000 to 262,768,000, a change of -20,977,000 (-7.4%).
- Net loss of 13,977,000 reduced equity.
- Dividend payments of 7,000,000 reduced retained earnings.
- Other comprehensive income decreased equity by 7,000,000.
- Other factors increased equity by 7,000,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | GBX-13.98 Million | -5.32% |
| Dividends Paid | GBX7.00 Million | -2.66% |
| Other Comprehensive Income | GBX-7.00 Million | -2.66% |
| Other Changes | GBX7.00 Million | +2.66% |
| Total Change | GBX- | -7.39% |
Book Value vs Market Value Analysis
This analysis compares Life Science REIT PLC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 57.41x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 43.03x to 57.41x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | GBX1.00 | GBX43.10 | x |
| 2022-12-31 | GBX0.91 | GBX43.10 | x |
| 2023-12-31 | GBX0.81 | GBX43.10 | x |
| 2024-12-31 | GBX0.75 | GBX43.10 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Life Science REIT PLC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -5.32%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -68.83%
- • Asset Turnover: 0.05x
- • Equity Multiplier: 1.53x
- Recent ROE (-5.32%) is below the historical average (-4.85%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | 2.21% | 95.33% | 0.02x | 1.03x | GBX-27.32 Million |
| 2022 | -8.64% | 0.00% | -0.04x | 1.40x | GBX-59.56 Million |
| 2023 | -7.65% | -108.85% | 0.05x | 1.45x | GBX-50.08 Million |
| 2024 | -5.32% | -68.83% | 0.05x | 1.53x | GBX-40.25 Million |
Industry Comparison
This section compares Life Science REIT PLC's net assets metrics with peer companies in the REIT - Healthcare Facilities industry.
Industry Context
- Industry: REIT - Healthcare Facilities
- Average net assets among peers: $60,213,000
- Average return on equity (ROE) among peers: -1.51%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Life Science REIT PLC (LABS) | GBX233.06 Million | 2.21% | 0.61x | $1.84 Million |
| Assura PLC (AGR) | $162.68 Million | -5.34% | 1.83x | $18.77 Million |
| Primary Health Properties (PHP) | $15.70 Million | 0.80% | 0.01x | $29.79 Million |
| Target Healthcare REIT Ltd (THRL) | $2.26 Million | 0.00% | 0.00x | $8.10 Million |
About Life Science REIT PLC
Life Science REIT plc is a specialist property business focused on the UK's growing life science sector. The Company's portfolio of assets is located across the Golden Triangle of research and development hubs in Oxford, Cambridge and London's Knowledge Quarter. Life Science REIT trades on the Main Market of the London Stock Exchange under the ticker LABS.